EBS PHARMA
ActiveSummary
EBS PHARMA has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20,714 and a net result of €22,677. Equity remains stable across the filed financial years (±1.2% per year). Its solvency ranks better than 46% of 1,861 sector peers (NACE 10, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- Other provision: “Naam en hoedanigheid van de instrumenterende notaris, hetzij van de perso(o)n(en) bevoegd de vereniging, stichting of het organisme ten…” (deed in Dutch)
Read from the deeds: 1 provision, deed of 01-10-2026